Johnson & Johnson price target raised to $290 from $280 at HSBC
HSBC raised the firm's price target on Johnson & Johnson to $290 from $280 and keeps a Buy rating on the shares. In a sector note on Healthcare, HSBC adjusted target prices on the prospects of the sector's relative outperformance potential for the second half of the year, noting that the Therapeutics space offering "at